103441-72-1

Basic information

• Product Name: Methyl 2-vinylnicotinate
• Synonyms: Methyl 2-vinylnicotinate;4-(1,2,3,6-tetrahydropyridin-4-yl)benzoic acid
• CAS NO: 103441-72-1
• Molecular Formula: C9H9NO2
• Molecular Weight: 163.17326
• Mol File: 103441-72-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 2-vinylnicotinate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-vinylnicotinate(103441-72-1)
• EPA Substance Registry System: Methyl 2-vinylnicotinate(103441-72-1)

Safety Data

• Hazardous Substances Data: 103441-72-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
Methyl 2-vinylnicotinate is used as an intermediate in the synthesis of pharmaceuticals for its potential biological activity. Its antioxidant and anti-inflammatory properties contribute to the development of drugs aimed at treating various conditions.
Used in Agrochemical Synthesis:
In the agrochemical industry, Methyl 2-vinylnicotinate is utilized as a precursor in the synthesis of agrochemicals, leveraging its biological activity to create compounds that can be used in agricultural applications.
Used in Organic Synthesis:
Methyl 2-vinylnicotinate is employed as a reagent in organic synthesis, where its unique structure and properties allow for the creation of new organic compounds for various applications.
Used in Materials Science:
In the field of materials science, Methyl 2-vinylnicotinate is used for the development of new materials, potentially contributing to advancements in areas such as polymer science and material engineering due to its versatile chemical structure.

Upstream product

• 40134-18-7 methyl 2-chloropyridine-3-carboxylate 
• 75927-49-0 pinacol vinylboronate 
• 379670-43-6 methyl 2-ethynylnicotinate 
• 379670-41-4 methyl 2-((trimethylsilyl)ethynyl)nicotinate 
• 2942-59-8 2-chloronicotinic acid 
• 7486-35-3 tri-n-butyl(vinyl)tin 

Downstream Products

• 155058-02-9 7,8-Dihydro-1,6-Naphthyridine-5(6H)-one 
• 5860-72-0 7,8-dihydro-5H-pyrano[4,3-b]pyridin-5-one 

Relevant articles and documents

MODULATORS OF HEMOGLOBIN

The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.

Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2

As part of an effort to identify novel selective modulators of sirtuins, we synthesized and tested several isosteres and constrained analogues of nicotinamide. Biological data suggest that compound 2 is selective for Sirt3 over Sirt1 and Sirt2.

Ready access to 7,8-dihydro- and 1,2,3,4-tetrahydro-1,6-naphthyridine-5(6H) -ones from simple pyridine precursors

Short pathways are described for the synthesis of a representative example of each of the 7,8-dihydro- and 1,2,3,4-tetrahydro-1,6-naphthyridine-5(6H)-one ring systems from simple pyridine precursors. An attempted synthesis of the related 4,6-dihydro-1,6-naphthyridin-5(1H)-one ring system from a common intermediate was unsuccessful.

Dihydro- and tetrahydronaphthyridines

This invention concerns novel dihydro- and tetrahydronaphthyridines useful for enhancing the lethal effects on tumor cells to treatment causing DNA-damaging activity as with ionizing radiation or with a chemotherapeutic agent.